IBRX Operating Expenses

Immunitybio Inc · Operating Expenses

IBRX logo

IBRX Operating Expenses

Latest reported$408.68M
IBRX Operating Expenses ($2.87M → $408.68M)
High-resolution chart · PNG

IBRX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
368,562,000
358,927,000
362,872,000
351,538,000
331,214,000
221,485,000
57,938,000
88,881,000
93,599,000
120,937,000
237,640,000
5,921,000
2,865,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.